Literature DB >> 27419387

The Enterobacterial Genotoxins: Cytolethal Distending Toxin and Colibactin.

Frederic Taieb1, Claude Petit1, Jean-Philippe Nougayrède1, Eric Oswald1.   

Abstract

While the DNA damage induced by ionizing radiation and by many chemical compounds and drugs is well characterized, the genotoxic insults inflicted by bacteria are only scarcely documented. However, accumulating evidence indicates that we are exposed to bacterial genotoxins. The prototypes of such bacterial genotoxins are the Cytolethal Distending Toxins (CDTs) produced by Escherichia coli and Salmonella enterica serovar Typhi. CDTs display the DNase structure fold and activity, and induce DNA strand breaks in the intoxicated host cell nuclei. E. coli and certain other Enterobacteriaceae species synthesize another genotoxin, colibactin. Colibactin is a secondary metabolite, a hybrid polyketide/nonribosomal peptide compound synthesized by a complex biosynthetic machinery. In this review, we summarize the current knowledge on CDT and colibactin produced by E. coli and/or Salmonella Typhi. We describe their prevalence, genetic determinants, modes of action, and impact in infectious diseases or gut colonization, and discuss the possible involvement of these genotoxigenic bacteria in cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27419387     DOI: 10.1128/ecosalplus.ESP-0008-2016

Source DB:  PubMed          Journal:  EcoSal Plus        ISSN: 2324-6200


  42 in total

1.  Model Colibactins Exhibit Human Cell Genotoxicity in the Absence of Host Bacteria.

Authors:  Emilee E Shine; Mengzhao Xue; Jaymin R Patel; Alan R Healy; Yulia V Surovtseva; Seth B Herzon; Jason M Crawford
Journal:  ACS Chem Biol       Date:  2018-11-20       Impact factor: 5.100

Review 2.  Virome and bacteriome: two sides of the same coin.

Authors:  Jonathan Stern; George Miller; Xin Li; Deepak Saxena
Journal:  Curr Opin Virol       Date:  2019-06-06       Impact factor: 7.090

Review 3.  Microbiota in cancer development and treatment.

Authors:  Muhammad Hassan Raza; Kamni Gul; Abida Arshad; Naveeda Riaz; Usman Waheed; Abdul Rauf; Fahad Aldakheel; Shatha Alduraywish; Maqbool Ur Rehman; Muhammad Abdullah; Muhammad Arshad
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-12       Impact factor: 4.553

Review 4.  Employing chemical synthesis to study the structure and function of colibactin, a "dark matter" metabolite.

Authors:  Peyton C Williams; Kevin M Wernke; Alina Tirla; Seth B Herzon
Journal:  Nat Prod Rep       Date:  2020-11-18       Impact factor: 13.423

Review 5.  Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective.

Authors:  Alan R Healy; Seth B Herzon
Journal:  J Am Chem Soc       Date:  2017-10-12       Impact factor: 15.419

6.  "Effect of Subinhibitory Concentrations of Some Antibiotics and Low Doses of Gamma Radiation on the Cytotoxicity and Expression of Colibactin by an Uropathogenic Escherichia coli isolate".

Authors:  Radwa N Morgan; Hala A Farrag; Mohammad M Aboulwafa; Sarra E Saleh
Journal:  Curr Microbiol       Date:  2021-01-03       Impact factor: 2.188

7.  Domain-Targeted Metabolomics Delineates the Heterocycle Assembly Steps of Colibactin Biosynthesis.

Authors:  Eric P Trautman; Alan R Healy; Emilee E Shine; Seth B Herzon; Jason M Crawford
Journal:  J Am Chem Soc       Date:  2017-03-10       Impact factor: 15.419

8.  Structure elucidation of colibactin and its DNA cross-links.

Authors:  Mengzhao Xue; Chung Sub Kim; Alan R Healy; Kevin M Wernke; Zhixun Wang; Madeline C Frischling; Emilee E Shine; Weiwei Wang; Seth B Herzon; Jason M Crawford
Journal:  Science       Date:  2019-08-08       Impact factor: 47.728

9.  Rab5a Promotes Cytolethal Distending Toxin B-Induced Cytotoxicity and Inflammation.

Authors:  Ming-Xian Chen; Yu Chen; Rui Fu; Guo-Qun Mao; Sai-Yue Liu; Tang-Biao Shen
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

10.  Effects of Gut Microbiome on Carcinogenic DNA Damage.

Authors:  Yun-Chung Hsiao; Chih-Wei Liu; Liang Chi; Yifei Yang; Kun Lu
Journal:  Chem Res Toxicol       Date:  2020-07-31       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.